2017 annual financial data
ADMA Biologics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -163.76%.
Operating income was -39,309,996 USD and net income was -43,758,975 USD.
Operating cash flow was -37,271,774 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 22,760,560 USD
- Operating income
- -39,309,996 USD
- Net income
- -43,758,975 USD
- Operating cash flow
- -37,271,774 USD